5 results
The primary objective of this study is to assess the objective response rates (ORR) for two starting doses of vandetanib, 150 mg and 300 mg in patients with unresectable locally advanced or metastatic MTC having progressive or symptomatic disease.…
Primary objective To investigate the safety and tolerability of CCS1477 as monotherapy and in combination.
Primary- Continuation of treatment- SafetySecondairy- Documentation of tolerability
The primary objectives of the study are:For Parts A through C:1. Evaluate the safety and tolerability of multiple doses of CX-072, administered as monotherapy or in combination with ipilimumab or vemurafenib to patients with metastatic or locally…
The main objective of this pilot study is to determine PKI concentration in tumor tissue after approximately two weeks of treatment.